Suzanah C. Boyd

1.2k total citations · 1 hit paper
8 papers, 896 citations indexed

About

Suzanah C. Boyd is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Suzanah C. Boyd has authored 8 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Suzanah C. Boyd's work include Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (2 papers) and Cancer Cells and Metastasis (1 paper). Suzanah C. Boyd is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (2 papers) and Cancer Cells and Metastasis (1 paper). Suzanah C. Boyd collaborates with scholars based in Australia, China and United Kingdom. Suzanah C. Boyd's co-authors include Helen Rizos, Richard A. Scolyer, Richard Kefford, Matteo S. Carlino, Georgina V. Long, Carina Fung, Gulietta M. Pupo, Branka Mijatov, Therese M. Becker and Alexander M. Menzies and has published in prestigious journals such as Clinical Cancer Research, Journal of Investigative Dermatology and Molecular Cancer.

In The Last Decade

Suzanah C. Boyd

8 papers receiving 890 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

2014 382 citations Helen Rizos, Alexander M. Menzies et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Suzanah C. Boyd

Since Specialization

Citations

This map shows the geographic impact of Suzanah C. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanah C. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanah C. Boyd more than expected).

Fields of papers citing papers by Suzanah C. Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanah C. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanah C. Boyd. The network helps show where Suzanah C. Boyd may publish in the future.

Co-authorship network of co-authors of Suzanah C. Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanah C. Boyd. A scholar is included among the top collaborators of Suzanah C. Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanah C. Boyd. Suzanah C. Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment 2025 ·Molecular Cancer ·Su Yin Lim, Suzanah C. Boyd, Russell J. Diefenbach, Helen Rizos	5
2	Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma 2018 ·Oncogenesis ·Mal Irvine, Ashleigh Stewart, Bernadette Pedersen, Suzanah C. Boyd, Richard Kefford, Helen Rizos	71
3	Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing 2017 ·Biomarker Research ·Gulietta M. Pupo, Suzanah C. Boyd, Carina Fung, Matteo S. Carlino, Alexander M. Menzies, Bernadette Pedersen, Peter A. Johansson, Nicholas K. Hayward, Richard Kefford, Richard A. Scolyer, Georgina V. Long, Helen Rizos	19
4	Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma 2015 ·Oncotarget ·Elin S. Gray, Helen Rizos, Anna Reid, Suzanah C. Boyd, Michelle R. Pereira, Johnny Lo, Varsha Tembe, James Freeman, Jenny Lee, Richard A. Scolyer, Kelvin Shenq Woei Siew, Chris Lomma, Adam Cooper, Muhammad A. Khattak, Tarek Meniawy, Georgina V. Long, Matteo S. Carlino, Michael Millward, Mel Ziman	260
5	Preexisting MEK1P124 Mutations Diminish Response to BRAF Inhibitors in Metastatic Melanoma Patients 2014 ·Clinical Cancer Research ·Matteo S. Carlino, Carina Fung, Hamideh Shahheydari, Jason R. Todd, Suzanah C. Boyd, Mal Irvine, Adnan Nagrial, Richard A. Scolyer, Richard Kefford, Georgina V. Long, Helen Rizos	53
6	BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact breakdown → 2014 ·Clinical Cancer Research ·Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Carina Fung, Jessica Hyman, Lauren E. Haydu, Branka Mijatov, Therese M. Becker, Suzanah C. Boyd, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, Richard Kefford, Richard A. Scolyer, Georgina V. Long	382
7	Oncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress 2013 ·Journal of Investigative Dermatology ·Amanda Croft, Kwang Hong Tay, Suzanah C. Boyd, Su Guo, Chen Chen Jiang, Fritz Lai, Hsin‐Yi Tseng, Lei Jin, Helen Rizos, Peter Hersey, Xu Dong Zhang	64
8	Oncogenic B-RAFV600E Signaling Induces the T-Box3 Transcriptional Repressor to Repress E-Cadherin and Enhance Melanoma Cell Invasion 2012 ·Journal of Investigative Dermatology ·Suzanah C. Boyd, Branka Mijatov, Gulietta M. Pupo, Sieu L. Tran, Kavitha Gowrishankar, Heather M. Shaw, Colin R. Goding, Richard A. Scolyer, Graham J. Mann, Richard Kefford, Helen Rizos, Therese M. Becker	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact